Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 57.0
(0.0%)
JPY 57.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.39 Billion JPY | -168.38% |
| 2022 | 2.03 Billion JPY | -21.15% |
| 2021 | 2.58 Billion JPY | 204.05% |
| 2020 | -2.48 Billion JPY | 24.46% |
| 2019 | -3.28 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -337.41 Million JPY | 7.04% |
| 2024 Q2 | -337.78 Million JPY | -0.11% |
| 2023 Q3 | -283.25 Million JPY | 6.18% |
| 2023 FY | -1.39 Billion JPY | -168.38% |
| 2023 Q2 | -301.92 Million JPY | 32.21% |
| 2023 Q1 | -445.36 Million JPY | -112.07% |
| 2023 Q4 | -362.97 Million JPY | -28.15% |
| 2022 Q3 | -554.67 Million JPY | 0.0% |
| 2022 FY | 2.03 Billion JPY | -21.15% |
| 2022 Q4 | 3.69 Billion JPY | 765.49% |
| 2021 FY | 2.58 Billion JPY | 204.05% |
| 2020 FY | -2.48 Billion JPY | 24.46% |
| 2019 FY | -3.28 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 333.489% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -180.459% |
| GNI Group Ltd. | 13.1 Billion JPY | 110.63% |
| Linical Co., Ltd. | 725.72 Million JPY | 292.017% |
| Trans Genic Inc. | 89.43 Million JPY | 1658.11% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 2.275% |
| Soiken Holdings Inc. | -610 Million JPY | -128.442% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -80.333% |
| AnGes, Inc. | -11.96 Billion JPY | 88.356% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | -24.332% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 85.371% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 1436.073% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -61.209% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | -24.757% |
| CanBas Co., Ltd. | -1.26 Billion JPY | -10.421% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -74.503% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -313.057% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | -15.628% |
| Kidswell Bio Corporation | -1.33 Billion JPY | -4.336% |
| PeptiDream Inc. | 6.77 Billion JPY | 120.574% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 27.797% |
| Ribomic Inc. | -1.11 Billion JPY | -24.845% |
| SanBio Company Limited | -4.53 Billion JPY | 69.299% |
| Healios K.K. | -3.37 Billion JPY | 58.76% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | -20.642% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 0.676% |
| StemRIM | -2.07 Billion JPY | 32.875% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 214.082% |
| FunPep Company Limited | -994 Million JPY | -40.192% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -56.792% |
| Stella Pharma Corporation | -760.3 Million JPY | -83.284% |
| TMS Co., Ltd. | -943.25 Million JPY | -47.735% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -79.717% |
| Cuorips Inc. | -588.48 Million JPY | -136.796% |
| K Pharma,Inc. | 366.05 Million JPY | 480.681% |
| Takara Bio Inc. | 3 Billion JPY | 146.404% |
| ReproCELL Incorporated | -409.29 Million JPY | -240.468% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 12696.14% |
| StemCell Institute Inc. | 413.75 Million JPY | 436.793% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 1064.321% |
| CellSeed Inc. | -697.77 Million JPY | -99.707% |